News
As FDA kicked off the drug user fee reauthorization process, Commissioner Marty Makary said he’d like to see lower fees paid ...
Prudence as practical wisdom combines foresight, judgment, and discretion. It is a gateway virtue for K-12 education.
There are more than 50 theories for the function of this 12-sided, pentagonal-faced bronze object — but archaeologists have ...
In biology textbooks and beyond, the human genome and DNA therein typically are taught in only one dimension. While it can be ...
HONG KONG, July 11, 2025 (EZ Newswire) -- Math Magic has officially launched Hitem3D, the world’s first AI-powered tool for ...
Shading brings 3D forms to life, beautifully carving out the shape of objects around us. Despite the importance of shading ...
AI-powered product recognition system reduces water use, speeds up checkout and supports staff training—while helping 49% of ...
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three internally developed ...
A new, non-opioid pain drug is here. Getting it to patients could be agony. After decades of research, Vertex Pharmaceuticals has an approved pain medicine. Can one of the most powerful biotechs ...
(RTTNews) - Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex Pharmaceuticals (VRTX) to utilize Orna's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results